Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, M.D., William Jacot, M.D., Ph.D., Toshinari Yamashita, M.D., Ph.D., Joohyuk Sohn, M.D. https://orcid.org/0000-0002-2303-2764, Maria Vidal, M.D., Ph.D., Eriko Tokunaga, M.D., Ph.D., Junji Tsurutani, M.D., Ph.D., +31 , for the DESTINY-Breast04 Trial Investigators* For many people, a breast cancer diagnosis is quickly followed by a secondContinueContinue reading “A New Category of Breast Cancer Is Changing Treatment Options”